Should You Buy AC Immune SA (ACIU) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
ACIU is not a good buy right now for a Beginner long-term investor with $50k–$100k who is impatient and doesn’t want to wait for a better entry. The stock is highly speculative (biotech), options imply extreme uncertainty (very high IV), recent quarter fundamentals deteriorated sharply, there are no near-term news catalysts, and pattern-based odds tilt negative over the next week/month.
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): no signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Technical Analysis
Price (pre-market) is 3.54, slightly below the pivot level (3.566), which suggests the stock is not reclaiming a key near-term level yet.
- Trend/Moving Averages: Bullish structure (SMA_5 > SMA_20 > SMA_200) supports a longer-term uptrend/backbone.
- Momentum: MACD histogram is negative (-0.0104) and negatively expanding, indicating weakening momentum despite the bullish MA stack.
- RSI(6): 51.57 (neutral), offering no strong buy timing signal.
- Key levels: Support S1=3.314 then S2=3.158. Resistance R1=3.818 then R2=3.974.
- Pattern-based projection (similar candlesticks): 70% chance of -2.46% next week and -6.84% next month, which argues against buying immediately.
